Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps
NG Burgess, M Pellise, KS Nanda, LF Hourigan… - Gut, 2016 - gut.bmj.com
Objective The serrated neoplasia pathway accounts for up to 30% of all sporadic colorectal
cancers (CRCs). Sessile serrated adenomas/polyps (SSA/Ps) with cytological dysplasia …
cancers (CRCs). Sessile serrated adenomas/polyps (SSA/Ps) with cytological dysplasia …
[HTML][HTML] Superficially serrated adenoma: a proposal for a novel subtype of colorectal serrated lesion
T Hashimoto, Y Tanaka, R Ogawa, T Mori, H Yoshida… - Modern Pathology, 2018 - Elsevier
We describe a series of colorectal polyps characterized by mixed adenomatous and
serrated features, herein referred to as superficially serrated adenomas. Twenty superficially …
serrated features, herein referred to as superficially serrated adenomas. Twenty superficially …
Traditional serrated adenoma: an overview of pathology and emphasis on molecular pathogenesis
Objective To provide an overview of the pathology and molecular pathogenesis of traditional
serrated adenomas (TSA). Design Describe the morphology and molecules that play a role …
serrated adenomas (TSA). Design Describe the morphology and molecules that play a role …
[HTML][HTML] Serrated neoplasia pathway as an alternative route of colorectal cancer carcinogenesis
SY Kim, TI Kim - Intestinal Research, 2018 - synapse.koreamed.org
In the past two decades, besides conventional adenoma pathway, a subset of colonic
lesions, including hyperplastic polyps, sessile serrated adenoma/polyps, and traditional …
lesions, including hyperplastic polyps, sessile serrated adenoma/polyps, and traditional …
Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA)
EE Torlakovic, JD Gomez, DK Driman… - The American journal …, 2008 - journals.lww.com
The morphologic distinction between various serrated polyps of the colorectum may be
challenging. The distinction between sessile serrated adenoma (SSA) and traditional …
challenging. The distinction between sessile serrated adenoma (SSA) and traditional …
A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma
T Kimura, E Yamamoto, H Yamano… - Official journal of the …, 2012 - journals.lww.com
OBJECTIVES: Sessile serrated adenomas (SSAs) are known to be precursors of sporadic
colorectal cancers (CRCs) with microsatellite instability (MSI), and to be tightly associated …
colorectal cancers (CRCs) with microsatellite instability (MSI), and to be tightly associated …
Serrated neoplasia—role in colorectal carcinogenesis and clinical implications
Colorectal cancer (CRC) is considered a heterogeneous disease, both regarding
pathogenesis and clinical behaviour. Four decades ago, the adenoma–carcinoma pathway …
pathogenesis and clinical behaviour. Four decades ago, the adenoma–carcinoma pathway …
Serrated colorectal cancer: Preclinical models and molecular pathways
A Aiderus, N Barker, V Tergaonkar - Trends in Cancer, 2024 - cell.com
Serrated lesions are histologically heterogeneous, and detection can be challenging as
these lesions have subtle features that may be missed by endoscopy. Furthermore, while …
these lesions have subtle features that may be missed by endoscopy. Furthermore, while …
[HTML][HTML] Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated …
JH Kim, JM Bae, NY Cho, GH Kang - Oncotarget, 2016 - ncbi.nlm.nih.gov
The presence or absence of MLH1 methylation may critically affect the heterogeneity of
colorectal carcinoma (CRC) with the CpG island methylator phenotype (CIMP). Here, we …
colorectal carcinoma (CRC) with the CpG island methylator phenotype (CIMP). Here, we …
Sessile serrated polyps: an important route to colorectal cancer
MF Kalady - Journal of the National Comprehensive Cancer …, 2013 - jnccn.org
The serrated neoplastic pathway accounts for approximately 30% of colorectal cancers.
Characterized by mutations in the oncogene BRAF, DNA promoter hypermethylation, and …
Characterized by mutations in the oncogene BRAF, DNA promoter hypermethylation, and …